Trial site
Medical Care & Research Sa de Cv
- 14running trials
- 4closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Lupus (SLE)5 trials
- Chronic kidney disease2 trials
- Dermatomyositis and polymyositis (myositis)2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Colorectal cancer1 trial
- Crohn's disease1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- Melanoma1 trial
- and 11 more
- Phase
- Phase 310 trials
- Phase 25 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting9 trials
- Completed4 trials
- Recruiting3 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Boehringer Ingelheim5 trials
- Janssen Research & Development, LLC4 trials
- Biogen3 trials
- Hoffmann-La Roche2 trials
- Daiichi Sankyo1 trial
- and 3 more
Running trials
Not yet recruiting
Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC
Active, not recruiting
The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)
Active, not recruiting
Active, not recruiting
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lupus (SLE)2 recruiting
- Crohn's disease1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Rheumatoid arthritis1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)
Site data: ClinicalTrials.govUpdated 14 Nov 2026